Synovial sarcoma is a rare and aggressive soft tissue cancer that most often develops near the joints of the arms or legs. In very rare cases, however, it can appear in unusual locations — including the skull and brain region. A newly published case report…
We are incredibly honored to share that the Synovial Sarcoma Foundation received First Place in the Advocacy in Action Award at the 16th Annual SPAGN Conference in Stockholm, Sweden. Hosted by the Sarcoma Patient Advocacy Global Network (SPAGN), this award recognizes advocacy initiatives making a…
Synovial Sarcoma Foundation Welcomes Lucia and Roberto Belluco to the Board of Directors
[Philadelphia, PA] The Synovial Sarcoma Foundation (SSF) is honored to welcome Lucia Manzinello Belluco and Roberto Belluco to its Board of Directors as the organization’s first European board members. Their appointment marks an important step in expanding the foundation’s international reach and strengthening collaboration across…
Primary Cardiac Synovial Sarcoma: A Rare and Challenging Diagnosis
Synovial sarcoma is a rare soft tissue cancer that most commonly develops near the joints of the arms or legs.…
Post-Surgical Complication in Synovial Sarcoma: Rare Case Highlights Pleural Aspergillosis Risk
A recent case report describes a rare but serious complication in a patient with metastatic synovial sarcoma of the lung—highlighting…
Rare Tumor Case Highlights Importance of Accurate Diagnosis in Sarcoma Care
A recent case report describes an extremely rare solitary fibrous tumor (SFT) occurring in the maxilla (upper jaw), highlighting the…
Rare Disease Drug Development and Synovial Sarcoma: Why Funding Still Falls Short
A recent BioSpace article highlights a critical challenge in rare disease drug development: many promising therapies are not limited by…
Synovial Sarcoma in Children: A Rare Case Affecting the Lung
Most synovial sarcoma tumors develop in the soft tissues near the joints of the arms or legs in adolescents and…
Synovial Sarcoma Research Pipeline Grows as 15+ Companies Develop New Therapies
Recent industry analyses show that the synovial sarcoma clinical trial pipeline is expanding, with more than 15 companies developing over…
Targeted Therapy Shows Promise in Rare BRAF-Mutated Synovial Sarcoma
Synovial sarcoma is a rare soft tissue sarcoma most commonly treated with surgery, chemotherapy, radiation therapy, and targeted drugs such…
Synovial Sarcoma Treatment Market Growth Reflects Expanding Research
Recent industry analyses suggest the synovial sarcoma treatment market is expected to grow steadily, with projections estimating a compound annual…
A Turning Point for Rare Cancers
What the UK’s Rare Cancers Bill Means for the Synovial Sarcoma Community For decades, patients diagnosed with rare cancers have…
